<DOC>
	<DOC>NCT01222377</DOC>
	<brief_summary>RATIONALE: Endoscopic breast surgery (EBS) is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. PURPOSE: This clinical trial studies endoscopic breast surgery in treating patients with breast cancer.</brief_summary>
	<brief_title>Endoscopic Breast Surgery in Treating Patients With Breast Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES: I. To determine the surgical complication rate in patients undergoing EBS for benign or malignant disease and the 5-year local recurrence rate following endoscopic breast surgery among subjects undergoing EBS for breast cancer at USC. SECONDARY OBJECTIVES: I. To evaluate the safety, breast cosmesis and patient quality of life following EBS. OUTLINE: Patients undergo endoscopic breast surgery. After completion of study treatment, patients are followed up every 6 months for 5 years.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Breast Neoplasms, Male</mesh_term>
	<criteria>Breast cancer or prophylactic mastectomy requiring axillary nodal staging Breast disease (e.g., fibroadenoma, ADH) Ability to read and/or comprehend consent form and questionnaires Ability to followup per protocol Not pregnant or breastfeeding Pregnant or breastfeeding Evidence of chest wall or skin* involvement NOTE: *may be endoscopyassisted</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>